Jeff Huber
General Partner at Triatomic Capital
San Francisco Bay Area
Overview
Work Experience
Co-Founder & Managing Director
2022 - Current
‘Applied AI’ in Deep tech, Health tech, & New economy // Helping great entrepreneurs build 'century-defining' businesses & technologies.
Deep tech. Health tech. New economy. AI. Helping great entrepreneurs build 'century-defining' technologies & businesses.
Board of Directors member (public)
2024
Bringing ivonescimab – a novel, first-in-class bi-specific antibody combining immunotherapy via PD-1 blockade and anti-angiogenesis via blocking VEGF in a single molecule – quickly and responsibly to clinical deployment, to help change cancer outcomes for millions of patients.
Board of Directors member
2024
d-Matrix powers next generation compute for generative AI and large language models.
D-Matrix is a computing platform that targets artificial intelligence inferencing workloads in the datacenter.
Raised $154,000,000.00 from Industry Ventures, Nautilus Venture Partners, M12 - Microsoft's Venture Fund, Playground Global, Lam Capital, Temasek Holdings, TGC Square, Cortes capital, Marlan Holding and Ericsson Ventures.
Board of Directors member
2022
Manifold Bio is a next-generation protein therapeutics company pioneering an in-vivo biologics design platform.
Manifold Bio is building a protein barcoding platform to bring the power of multiplexed measurement.
Raised $45,399,985.00 from FAST — by GETTYLAB, Tencent, Triatomic Capital, Fifty Years, Section 32, Playground Global, FPV Ventures and Horizons Ventures.
Board of Directors member
2022
A new AI social platform where you can create, share, and interact with Al bots live with friends.
Board of Directors member (public)
2021
Upstart's mission is to enable effortless credit based on true risk, enabled by AI/ML.
Upstart (NASDAQ: UPST) is a leading AI lending marketplace partnering with banks and credit unions to expand access to affordable credit.
Raised $944,050,000.00 from First National Bank Of Omaha, Progressive, Healthcare of Ontario Pension Plan (HOOPP), Rakuten, First Round Capital, Khosla Ventures, Green D Ventures and Third Point Ventures.
Board of Directors member
2020
Mammoth Biosciences is building the CRISPR platform for the next generation of therapeutics and cell/gene therapies.
Mammoth Biosciences develops novel CRISPR applications for disease detection, research, agriculture, biodefense, and more.
Raised $264,545,000.00 from Bradley Horowitz, Plum Alley, Decheng Capital, Senator Investment Group, Redmile Group, Sixth Street, Foresite Capital, NFX, Tachyon Ventures and Mayfield Fund.
Board of Directors member
2018
Openwater is creating a new generation of imaging technologies to change how we read and write our bodies and brains.
Chairman / Board of Directors member
2019
Genalyte is a healthcare analytics & diagnostics company improving patient outcomes with real-time point-of-care results.
Genalyte is a life sciences company developing and commercializing innovative next-generation multiplexing technology.
Raised $154,800,000.00 from HBM Partners and Claremont Creek Ventures.
Board of Directors member (public)
2009
Member of Nomination & Governance (2010-2012) and Audit (2012-present) Committees. Helped focus EA’s transition from retail to online/cloud & mobile delivery. Valuation increased >800% over tenure.
Electronic Arts delivers games, content, and online services for internet-connected consoles, PCs, mobile phones, and tablets.
Raised $2,200,000.00 from TCV and TCV.